Enovix Names Hongwei Yan as Chief Technology Officer-March 2024-www.financetom.com

Enovix Names Hongwei Yan as Chief Technology Officer

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Enovix Names Hongwei Yan as Chief Technology Officer

Nov 26, 2024 5:25 AM

08:04 AM EST, 11/26/2024 (MT Newswires) -- Enovix ( ENVX ) said Tuesday that Hongwei Yan has been named chief technology officer.

Reporting directly to CEO Raj Talluri, Yan will lead technology development, customer qualification, and the 2025 scale-up of the company's high-volume manufacturing plant in Malaysia, the company said.

Previous page： JPMorgan names heads for healthcare, tech investment banking Next page： BRIEF-High Roller Technologies Inc Sees IPO Of Up To 1.25 Million Shares Of Common Stock - SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

JPMorgan names heads for healthcare, tech investment banking

Sep 22, 2024

(Reuters) - JPMorgan Chase ( JPM ) announced on Thursday leadership changes in a push to strengthen its healthcare and technology investment banking, according to an internal memo seen by Reuters. Ben Carpenter and Jeremy Meilman would be the global co-heads of healthcare investment banking, while Chris Grose and Greg Mendelson have been named global co-heads of the technology investment...

BRIEF-High Roller Technologies Inc Sees IPO Of Up To 1.25 Million Shares Of Common Stock - SEC Filing

Sep 22, 2024

High Roller Technologies Inc: * HIGH ROLLER TECHNOLOGIES INC SEES IPO OF UP TO 1.25 MILLION SHARES OF COMMON STOCK - SEC FILING * HIGH ROLLER TECHNOLOGIES INC -ANTICIPATE THAT THE INITIAL PUBLIC OFFERING PRICE WILL BE $8.00 PER SHARE OF COMMON STOCK Source text for Eikon: Further company coverage: ...

Vaxcyte Insider Sold Shares Worth $927,551, According to SEC Filing

Sep 22, 2024

05:59 PM EDT, 09/19/2024 (MT Newswires) -- Andrew Guggenhime, PRESIDENT AND CFO, on September 18, 2024, sold 8,000 shares in Vaxcyte ( PCVX ) for $927,551. Following the Form 4 filing with the SEC, Guggenhime has control over a total of 90,383 shares of the company, with 90,383 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649094/000164909424000071/xslF345X05/wk-form4_1726782498.xml ...

Gentherm Insider Sold Shares Worth $752,791, According to SEC Filing

Sep 22, 2024

05:56 PM EDT, 09/19/2024 (MT Newswires) -- Phillip Eyler, Director, President & CEO, on September 17, 2024, sold 15,000 shares in Gentherm ( THRM ) for $752,791. Following the Form 4 filing with the SEC, Eyler has control over a total of 147,317 shares of the company, with 147,317 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/903129/000095017024108211/xslF345X05/ownership.xml ...